Finance News – Sonnet Biotherapeutics
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Hyperliquid Strategies Inc. plan for $583M treasury boosts HYPE price
The creation of a $583 million treasury by Hyperliquid Strategies Inc. following the Sonnet BioTherapeutics and Rorschach merger has contributed to a notable increase in the value...
Read Full Article →Sonnet ditches biotech dreams to anchor a $583m HYPE token reserve
Sonnet BioTherapeutics’ recent merger positions the company to manage a substantial digital asset reserve, reflecting a strategic shift that integrates conventional pharmaceutical...
Read Full Article →Sonnet BioTherapeutics agrees to $888 million crypto treasury deal
Sonnet BioTherapeutics has entered into a significant agreement involving digital assets valued at $888 million, potentially impacting its financial strategy and strengthening its...
Read Full Article →Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies,...
The merger valued at $888 million will transform Sonnet BioTherapeutics into Hyperliquid Strategies, which is projected to possess 12.6 million HYPE tokens and $305 million in cash...
Read Full Article →